康芝藥業(300086.SZ):擬向相關金融機構申請合計不超15億元綜合授信額度
格隆匯4月6日丨康芝藥業(300086.SZ)公佈,為滿足公司生產經營及項目投資資金需求,公司及下屬全資子公司、控股子公司、控股孫公司擬向相關金融機構申請合計不超過人民幣15億元綜合授信額度,並為金融機構綜合授信額度內的貸款提供不超過15億元的連帶責任保證擔保。
上述綜合授信主要用於公司及下屬全資子公司、控股子公司、控股孫公司日常生產經營、項目投資建設及併購投資的長、短期貸款、流動資金貸款、抵押貸款、銀行承兑匯票、貿易融資、保函、開立信用證、以票質票、票據質押貸款等金融單位授信業務。具體授信額度以公司與銀行等相關金融機構簽訂的具體合同為準。授信期限內,授信額度可循環使用。針對上述金融機構綜合授信下的具體業務,公司及下屬全資子公司、控股子公司、控股孫公司之間可互相提供擔保。擔保額度不超過15億元,擔保方式為連帶責任保證擔保、抵押擔保、質押擔保。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.